Fuller & Thaler Asset Management’s Eli Lilly LLY Stock Holding History

Fuller & Thaler Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.9M	Hold	2,420	–	–	0.01%	355
2026 Q1	$2.23M	Sell	2,420 -303	-11%	-$307K	0.01%	361
2025 Q4	$2.93M	Hold	2,723	–	–	0.01%	352
2025 Q3	$2.08M	Sell	2,723 -544	-17%	-$405K	0.01%	364
2025 Q2	$2.55M	Hold	3,267	–	–	0.01%	362
2025 Q1	$2.7M	Hold	3,267	–	–	0.01%	352
2024 Q4	$2.52M	Hold	3,267	–	–	0.01%	355
2024 Q3	$2.89M	Hold	3,267	–	–	0.01%	345
2024 Q2	$2.96M	Hold	3,267	–	–	0.01%	339
2024 Q1	$2.54M	Sell	3,267 -512	-14%	-$364K	0.01%	352
2023 Q4	$2.2M	Buy	3,779 +725	+24%	+$423K	0.01%	353
2023 Q3	$1.64M	Buy	3,054 +200	+7%	+$103K	0.01%	362
2023 Q2	$1.34M	Buy	2,854 +699	+32%	+$293K	0.01%	374
2023 Q1	$740K	Hold	2,155	–	–	﹤0.01%	394
2022 Q4	$788K	Sell	2,155 -1,275	-37%	-$452K	0.01%	375
2022 Q3	$1.11M	Sell	3,430 -2,509	-42%	-$795K	0.01%	366
2022 Q2	$1.93M	Sell	5,939 -3,500	-37%	-$1.05M	0.01%	358
2022 Q1	$2.7M	Sell	9,439 -3,200	-25%	-$824K	0.02%	341
2021 Q4	$3.49M	Sell	12,639 -1,800	-12%	-$456K	0.02%	300
2021 Q3	$3.34M	Sell	14,439 -1,000	-6%	-$247K	0.02%	287
2021 Q2	$3.54M	Sell	15,439 -2,600	-14%	-$522K	0.02%	279
2021 Q1	$3.37M	Sell	18,039 -3,400	-16%	-$665K	0.02%	285
2020 Q4	$3.62M	Buy	21,439 +39	+0.2%	+$5.82K	0.03%	263
2020 Q3	$3.17M	Hold	21,400	–	–	0.04%	257
2020 Q2	$3.51M	Hold	21,400	–	–	0.05%	245
2020 Q1	$2.97M	Sell	21,400 -6,600	-24%	-$907K	0.05%	239
2019 Q4	$3.68M	Buy	+28,000	New	+$3.25M	0.04%	236
2018 Q3	–	Sell	-5,200	Closed	-$444K	–	608
2018 Q2	$444K	Hold	5,200	–	–	﹤0.01%	364
2018 Q1	$402K	Sell	5,200 -5,700	-52%	-$459K	﹤0.01%	370
2017 Q4	$921K	Hold	10,900	–	–	0.01%	317
2017 Q3	$932K	Sell	10,900 -600	-5%	-$49.2K	0.01%	292
2017 Q2	$946K	Hold	11,500	–	–	0.01%	288
2017 Q1	$967K	Hold	11,500	–	–	0.01%	268
2016 Q4	$846K	Hold	11,500	–	–	0.01%	266
2016 Q3	$923K	Buy	11,500 +6,200	+117%	+$496K	0.02%	243
2016 Q2	$417K	Hold	5,300	–	–	0.01%	287
2016 Q1	$382K	Buy	5,300 +1,300	+33%	+$98.4K	0.01%	294
2015 Q4	$337K	Hold	4,000	–	–	0.01%	315
2015 Q3	$335K	Sell	4,000 -2,200	-35%	-$186K	0.01%	327
2015 Q2	$518K	Sell	6,200 -3,400	-35%	-$259K	0.01%	304
2015 Q1	$697K	Sell	9,600 -6,400	-40%	-$456K	0.02%	301
2014 Q4	$1.1M	Sell	16,000 -100	-0.6%	-$6.75K	0.04%	257
2014 Q3	$1.04M	Buy	16,100 +4,500	+39%	+$285K	0.04%	260
2014 Q2	$721K	Buy	11,600 +4,700	+68%	+$280K	0.03%	287
2014 Q1	$406K	Sell	6,900 -4,600	-40%	-$257K	0.02%	338
2013 Q4	$587K	Hold	11,500	–	–	0.03%	285
2013 Q3	$579K	Sell	11,500 -5,300	-32%	-$277K	0.03%	286
2013 Q2	$825K	Buy	+16,800	New	+$914K	0.06%	255

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fuller & Thaler Asset Management's LLY Position: Q2 2026 in Review

Fuller & Thaler Asset Management held its Eli Lilly (LLY) position steady in Q2 2026 at 2,420 shares worth $2.9M. The position accounts for 0.01% of the portfolio, ranked #355.

Fuller & Thaler Asset Management first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. The position peaked at $3.68M in Q4 2019. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Fuller & Thaler Asset Management held 2,420 shares of Eli Lilly worth $2.9M as of Q2 2026.
Fuller & Thaler Asset Management left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.01% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #355 holding.
Fuller & Thaler Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
Fuller & Thaler Asset Management's Eli Lilly position peaked at $3.68M in Q4 2019.
4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.